• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE® VIABAHN® ENDOPROSTHESIS; NIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE® VIABAHN® ENDOPROSTHESIS; NIP Back to Search Results
Device Problems Fluid/Blood Leak (1250); Leak/Splash (1354)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 01/01/2016
Event Type  Injury  
Manufacturer Narrative
Udi # remain unknown.(b)(4).The article stated that two gore viabahn® endoprostheses were involved in the medical device incident.Multiple attempts have been made from the product surveillance coordinator to the author in order to get the lot numbers of the devices.As no further information related to this case has been or will be provided by the author, gore is submitting one report for the medical devices involved in the incident.Since the actual date of the incident is not available the year (january 1, 2016) when the patient was treated with the medical device was used as an estimated date of the incident.
 
Event Description
Within the article ¿endovascular repair of 40 visceral artery aneurysms and pseudoaneurysms with the viabahn stent-graft: technical aspects, clinical outcome and mid-term patency¿, published by massimo venturini et al, within the (b)(6) 2017, clinical investigation abstract, accepted on november 13, 2017, the published results indicated the following: the purpose of this single-center study was to retrospectively report a 14-year experience with the peripheral, self-expandable viabahn stent-graft in the endovascular repair of 40 visceral artery aneurysms (vaa) and visceral artery pseudoaneurysms (vapa).As primary outcomes, peri-procedural complications, technical success 30-day clinical success, re-interventions and 30-day mortality were assessed.As secondary outcomes, stent-graft patency and persistent aneurysm devascularization at mid- (6¿12 months) and long-term (more than 12 months) were assessed.Patient b19 (male/(b)(6)) presented with a vapa within the middle gastroduodenal artery, which was treated with two gore® viabahn® endoprostheses (7 mm x 2,5 cm; 7 mm x 2,5 cm), where the approach was gained through the right femoral artery, in an emergency procedure 2016 suffered from a re-bleeding of the gastroduodenal artery stump which required a reintervention with a gore® viabahn® endoprosthesis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® VIABAHN® ENDOPROSTHESIS
Type of Device
NIP
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
barbara ulrich
1500 n. 4th street
flagstaff, AZ 
9285263030
MDR Report Key7128707
MDR Text Key95213765
Report Number2017233-2017-00658
Device Sequence Number1
Product Code PFV
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
P130006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,litera
Reporter Occupation Physician
Type of Report Initial
Report Date 11/29/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/19/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age75 YR
-
-